AAAAAA

   
Results: 1-21 |
Results: 21
RESPONSE-ADAPTED SEQUENTIAL COMBINATION CHEMOTHERAPY (CEBOPP VIML) FOLLOWED BY RADIOTHERAPY FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE/
Authors: NOWROUSIAN MR WELT A FOSSA A KASPER C SCHRODER J KUHLMANN S SCHUTTE J KLOKE O STUSCHKE M SCHULEHEIN K METZ KA LEDER LD SACK H SEEBER S
Citation: Mr. Nowrousian et al., RESPONSE-ADAPTED SEQUENTIAL COMBINATION CHEMOTHERAPY (CEBOPP VIML) FOLLOWED BY RADIOTHERAPY FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE/, Annals of oncology, 9, 1998, pp. 514-514
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA AND PREVENTION OF TRANSFUSION REQUIREMENT ASSOCIATED WITH SOLID TUMORS - A RANDOMIZED, CONTROLLED-STUDY
Authors: OBERHOFF C NERI B AMADORI D PETRY KU GAMUCCI T REBMANN U NOWROUSIAN MR VOIGTMANN R MONFARDINI S ARMAND JP HERRMANN R NETTERPINON J TUBIANAMATHIEU N ZWIERZINA H
Citation: C. Oberhoff et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA AND PREVENTION OF TRANSFUSION REQUIREMENT ASSOCIATED WITH SOLID TUMORS - A RANDOMIZED, CONTROLLED-STUDY, Annals of oncology, 9(3), 1998, pp. 255-260
GEMCITABINE AS SINGLE-AGENT IN THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN-LYMPHOMA (NHL)
Authors: WELT A FOSSA A BLATTER J BUKSMAUI S SEEBER S NOWROUSIAN MR
Citation: A. Welt et al., GEMCITABINE AS SINGLE-AGENT IN THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN-LYMPHOMA (NHL), Annals of oncology, 9, 1998, pp. 643-643
BOLUS VINCRISTINE AND EPIRUBICIN WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE (VECD) AS INDUCTION AND SALVAGE TREATMENT IN MULTIPLE-MYELOMA
Authors: FOSSA A MUER M KASPER C WELT A SEEBER S NOWROUSIAN MR
Citation: A. Fossa et al., BOLUS VINCRISTINE AND EPIRUBICIN WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE (VECD) AS INDUCTION AND SALVAGE TREATMENT IN MULTIPLE-MYELOMA, Leukemia, 12(3), 1998, pp. 422-426
RADIOTHERAPY FOR DISSEMINATED HIGHLY MALIGNANT NON-HODGKINS-LYMPHOMA - COMMENT ON ARTICLE BY KAISER,U., PFAB,R., HAVEMANN,K
Authors: STUSCHKE M NOWROUSIAN MR
Citation: M. Stuschke et Mr. Nowrousian, RADIOTHERAPY FOR DISSEMINATED HIGHLY MALIGNANT NON-HODGKINS-LYMPHOMA - COMMENT ON ARTICLE BY KAISER,U., PFAB,R., HAVEMANN,K, Strahlentherapie und Onkologie, 174(4), 1998, pp. 220-220
INITIAL HIGH-DOSE SEQUENTIAL CHEMOTHERAPY IN THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH RISK-FACTORS
Authors: WELT A ANHUF J KRAWCZYK C FOSSA A STUSCHKE M KLOKE O SCHUTTE J WESTERHAUSEN M SACK H SEEBER S NOWROUSIAN MR
Citation: A. Welt et al., INITIAL HIGH-DOSE SEQUENTIAL CHEMOTHERAPY IN THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH RISK-FACTORS, British Journal of Haematology, 102(1), 1998, pp. 237-237
HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL STEM-CELLTRANSPLANTATION IN PATIENTS WITH PREVIOUSLY TREATED OR UNTREATED MULTIPLE-MYELOMA
Authors: KUHLMANN S FOSSA A WRZECIONO T KASPER C WELT A SEEBER S NOWROUSIAN MR
Citation: S. Kuhlmann et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL STEM-CELLTRANSPLANTATION IN PATIENTS WITH PREVIOUSLY TREATED OR UNTREATED MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 352-353
RECURRENCE OF HODGKINS-DISEASE AFTER 10 OR MORE YEARS - LATE RELAPSE OR DE-NOVO MALIGNANCY DUE TO HLA-DPB1-ASTERISK-0301-LINKED SUSCEPTIBILITY
Authors: SIEBERT R FOSSA A KAISER W WELT A FERENCIK S SEEBER S NOWROUSIAN MR
Citation: R. Siebert et al., RECURRENCE OF HODGKINS-DISEASE AFTER 10 OR MORE YEARS - LATE RELAPSE OR DE-NOVO MALIGNANCY DUE TO HLA-DPB1-ASTERISK-0301-LINKED SUSCEPTIBILITY, Leukemia & lymphoma, 26(1-2), 1997, pp. 121-125
INTENSIFIED SALVAGE THERAPY FOR GERM-CELL CANCER USING SEQUENTIAL CYCLES OF HIGH-DOSE CARBOPLATIN ETOPOSIDELCYDO-PHOSPHAMIDE (CEC)/
Authors: HARSTRICK A FOSSA A ZASADZINSKI E MAYER S BOJKO P FLASSHOVE M NOWROUSIAN MR SCHUTTE J SEEBER S
Citation: A. Harstrick et al., INTENSIFIED SALVAGE THERAPY FOR GERM-CELL CANCER USING SEQUENTIAL CYCLES OF HIGH-DOSE CARBOPLATIN ETOPOSIDELCYDO-PHOSPHAMIDE (CEC)/, European journal of cancer, 33, 1997, pp. 167-167
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CANCER-RELATED ANEMIA
Authors: KASPER C TERHAAR A FOSSA A WELT A SEEBER S NOWROUSIAN MR
Citation: C. Kasper et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CANCER-RELATED ANEMIA, European journal of haematology, 58(4), 1997, pp. 251-256
SIMULTANEOUS MEASUREMENT OF CELLULAR P-GLYCOPROTEIN CONTENT AND FUNCTION BY FLOW-CYTOMETRY
Authors: MULLER MR LENNARTZ K BAACK B NOWROUSIAN MR EBERHARDT W THOMALE J RAJEWSKY MF SEEBER S
Citation: Mr. Muller et al., SIMULTANEOUS MEASUREMENT OF CELLULAR P-GLYCOPROTEIN CONTENT AND FUNCTION BY FLOW-CYTOMETRY, Experimental hematology, 24(9), 1996, pp. 302-302
ANALYSIS OF THE NOVEL CYCLIN-DEPENDENT KINASE-4 AND KINASE-6 INHIBITOR GENE P18 IN LYMPHOMA AND LEUKEMIA-CELL LINES
Authors: SIEBERT R WILLERS CP FOSSA A KLOKE O NOWROUSIAN MR SEEBER S OPALKA B
Citation: R. Siebert et al., ANALYSIS OF THE NOVEL CYCLIN-DEPENDENT KINASE-4 AND KINASE-6 INHIBITOR GENE P18 IN LYMPHOMA AND LEUKEMIA-CELL LINES, Leukemia research, 20(2), 1996, pp. 197-200
BCR REARRANGEMENT WITHOUT JUXTAPOSITION OF ABL IN PRE-T ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: FOSSA A SIEBERT R KASPER C BECHER R OPALKA B THIEL E SEEBER S NOWROUSIAN MR
Citation: A. Fossa et al., BCR REARRANGEMENT WITHOUT JUXTAPOSITION OF ABL IN PRE-T ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 93(2), 1996, pp. 403-405
RESULTS OF A MULTIMODALITY PREOPERATIVE INDUCTION TREATMENT PROGRAM IN LOCALLY ADVANCED (LAD) NSCLC STAGES IIIA AND IIIB
Authors: EBERHARDT W WILKE H STAMATIS G STUSCHKE M MENKER H MULLER MR STAHL M FUTHS U KLAASSEN U SCHLENGER L HAARSTRICK A BUDACH V NOWROUSIAN MR GRESHUCHNA D KONIETZKO N SEEBER S
Citation: W. Eberhardt et al., RESULTS OF A MULTIMODALITY PREOPERATIVE INDUCTION TREATMENT PROGRAM IN LOCALLY ADVANCED (LAD) NSCLC STAGES IIIA AND IIIB, European journal of cancer, 31A, 1995, pp. 1065-1065
D-19575 - A SUGAR-LINKED ISOPHOSPHORAMIDE MUSTARD DERIVATIVE EXPLOITING TRANSMEMBRANE GLUCOSE-TRANSPORT
Authors: POHL J BERTRAM B HILGARD P NOWROUSIAN MR STUBEN J WIESSLER M
Citation: J. Pohl et al., D-19575 - A SUGAR-LINKED ISOPHOSPHORAMIDE MUSTARD DERIVATIVE EXPLOITING TRANSMEMBRANE GLUCOSE-TRANSPORT, Cancer chemotherapy and pharmacology, 35(5), 1995, pp. 364-370
HOMOZYGOUS LOSS OF THE MTS1 P16 AND MTS2/P15 GENES IN LYMPHOMA AND LYMPHOBLASTIC-LEUKEMIA CELL-LINES/
Authors: SIEBERT R WILLERS CP SCHRAMM A FOSSA A DRESEN IMG UPPENKAMP M NOWROUSIAN MR SEEBER S OPALKA B
Citation: R. Siebert et al., HOMOZYGOUS LOSS OF THE MTS1 P16 AND MTS2/P15 GENES IN LYMPHOMA AND LYMPHOBLASTIC-LEUKEMIA CELL-LINES/, British Journal of Haematology, 91(2), 1995, pp. 350-354
CONCOMITANT GRANULOCYTE-COLONY-STIMULATING FACTOR AND INDUCTION CHEMORADIOTHERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III TRIAL
Authors: OTTMANN OG HOELZER D GRACIEN E GANSER A KELLY K REUTZEL R LIPP T BUSCH FW SCHWONZEN M HEIL G WANDT H KOCH P KOLBE K HEYLL A BENTZ M PETERS S DIEDRICH H DETHLING J MEYER P NOWROUSIAN MR LOFFLER B WEISS A KNEBA M FOLLER A GRAF M HECHT T
Citation: Og. Ottmann et al., CONCOMITANT GRANULOCYTE-COLONY-STIMULATING FACTOR AND INDUCTION CHEMORADIOTHERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III TRIAL, Blood, 86(2), 1995, pp. 444-450
IMPROVED FLOW-CYTOMETRIC DETECTION OF LOW P-GLYCOPROTEIN EXPRESSION IN LEUKEMIC BLASTS BY HISTOGRAM SUBTRACTION ANALYSIS
Authors: MULLER MR LENNARTZ K NOWROUSIAN MR DUX R TSURUO T RAJEWSKY MF SEEBER S
Citation: Mr. Muller et al., IMPROVED FLOW-CYTOMETRIC DETECTION OF LOW P-GLYCOPROTEIN EXPRESSION IN LEUKEMIC BLASTS BY HISTOGRAM SUBTRACTION ANALYSIS, Cytometry, 15(1), 1994, pp. 64-72
CYTOMORPHOLOGICAL FEATURES AND PROGNOSTIC FACTORS IN 33 PATIENTS WITHACUTE MYELOID-LEUKEMIA (AML) AND TRANSLOCATION (8 21)
Authors: HAFERLACH T LOFFLER H GASSMANN W BENNETT JM LUDWIG WD MASCHMEYER G THIEL E NOWROUSIAN MR LANG R KUBICA U WEISS A LENGFELDER E KOCH P WEH HJ TIRIER C SAUERLAND MC HEINECKE A BUCHNER T
Citation: T. Haferlach et al., CYTOMORPHOLOGICAL FEATURES AND PROGNOSTIC FACTORS IN 33 PATIENTS WITHACUTE MYELOID-LEUKEMIA (AML) AND TRANSLOCATION (8 21), Blood, 84(10), 1994, pp. 10000308-10000308
CLINICAL ASPECTS OF ACUTE MYELOID LEUKEMIAS OF THE FAB TYPE-M3 AND TYPE-M4EO
Authors: HAFERLACH T GASSMANN W LOFFLER H JURGENSEN C NOAK J LUDWIG WD THIEL E HAASE D FONATSCH C BECHER R SCHLEGELBERGER B NOWROUSIAN MR LENGFELDER E EIMERMACHER H WEH HJ BRAUMANN D MASCHMEYER G KOCH P HEINECKE A SAUERLAND MC BUCHNER T
Citation: T. Haferlach et al., CLINICAL ASPECTS OF ACUTE MYELOID LEUKEMIAS OF THE FAB TYPE-M3 AND TYPE-M4EO, Annals of hematology, 66(4), 1993, pp. 165-170
MULTIDRUG-RESISTANCE AND GLUTATHIONE REDOX CYCLE CAPACITY IN ACUTE MYELOID-LEUKEMIA
Authors: REITER WW BRANDHORST D NOWROUSIAN MR TSURUO Y WETTER O SEEBER S
Citation: Ww. Reiter et al., MULTIDRUG-RESISTANCE AND GLUTATHIONE REDOX CYCLE CAPACITY IN ACUTE MYELOID-LEUKEMIA, Experimental hematology, 21(8), 1993, pp. 1078-1078
Risultati: 1-21 |